Advertisement

Foot-and-mouth Disease

  • Vanesa Ruiz
  • Andrés Wigdorovitz
Chapter

Abstract

Foot-and-mouth disease remains one of the most feared viral diseases affecting cloven-hoofed animals such as cattle, pigs, sheep and goats. The disease has been successfully eradicated from some regions like North America, Western Europe and Australia, but it is still endemic in most of the world. Although mortality is generally low in adult animals, outbreaks result in devastating economic consequences due to production losses and a major constraint to international trade of live animals and their products. Immunization with the current inactivated vaccine has been successfully used in many parts of the world. However, its production process requires the growth of large amounts of infectious virus in high-level bio-containment facilities, which is not only very expensive but carries the risk of escape of live virus during vaccine manufacture and/or incomplete inactivation. Because of these hazards and other limitations, such as thermal instability, short duration of immunity and lack of cross protection, intense research focused on the design of improved vaccines, has been developed. Important issues concerning foot-and-mouth disease occurrence, pathogenesis and vaccine development, are reviewed in this chapter.

Keywords

Foot-and-mouth disease pathogenesis plant-made vaccines inactivated vaccine alternative vaccines 

References

  1. Abrams CC, King AM, Belsham GJ (1995) Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. J Gen Virol 76:3089–3098CrossRefPubMedGoogle Scholar
  2. Alexandersen S, Brotherhood I, Donaldson AI (2002a) Natural aerosol transmission of foot-and-mouth disease virus to pigs: minimal infectious dose for strain O-1 Lausanne. Epidemiol Infect 128:301–312.  https://doi.org/10.1017/s095026880100646xCrossRefPubMedPubMedCentralGoogle Scholar
  3. Alexandersen S, Donaldson AI (2002) Further studies to quantify the dose of natural aerosols of foot-and-mouth disease virus for pigs. Epidemiol Infect 128:313–323.  https://doi.org/10.1016/S0034-5288(02)90037-8CrossRefPubMedPubMedCentralGoogle Scholar
  4. Alexandersen S, Mowat N (2005) Foot-and-mouth disease virus: host range and pathogenesis. Curr Top Microbiol Immunol 288:9–42.  https://doi.org/10.1007/b138628CrossRefPubMedGoogle Scholar
  5. Alexandersen S, Oleksiewicz MB, Donaldson AI (2001) The early pathogenesis of foot-and-mouth disease in pigs infected by contact: A quantitative time-course study using TaqMan RT-PCR. J Gen Virol 82:747–755.  https://doi.org/10.1099/0022-1317-82-4-747CrossRefPubMedGoogle Scholar
  6. Alexandersen S, Zhang Z, Donaldson AI (2002b) Aspects of the persistence of foot-and-mouth disease virus in animals—the carrier problem. Microbes Infect 4:1099–1110.  https://doi.org/10.1016/S1286-4579(02)01634-9CrossRefPubMedGoogle Scholar
  7. Alexandersen S, Zhang Z, Donaldson AI, Garland AJM (2003) The Pathogenesis and Diagnosis of Foot-and-Mouth Disease. J Comp Pathol 129:1–36.  https://doi.org/10.1016/S0021-9975(03)00041-0CrossRefPubMedGoogle Scholar
  8. Andrianova EP, Krementsugskaia SR, Lugovskaia NN, et al (2011) Foot and mouth disease virus polyepitope protein produced in bacteria and plants induces protective immunity in guinea pigs. Biochem Biokhimii͡a 76:339–46.CrossRefGoogle Scholar
  9. Arzt J, Baxt B, Grubman MJ et al (2011) The Pathogenesis of Foot-and-Mouth Disease II: Viral Pathways in Swine, Small Ruminants, and Wildlife; Myotropism, Chronic Syndromes, and Molecular Virus-Host Interactions. Transbound Emerg Dis 58:305–326.  https://doi.org/10.1111/j.1865-1682.2011.01236.xCrossRefPubMedGoogle Scholar
  10. Arzt J, Gregg DA, Clavijo A, Rodriguez LL (2009) Optimization of immunohistochemical and fluorescent antibody techniques for localization of Foot-and-mouth disease virus in animal tissues. J Vet Diagnostic Investig 21:779–792.  https://doi.org/10.1177/104063870902100604CrossRefGoogle Scholar
  11. Arzt J, Pacheco JM, Rodriguez LL (2010) The early pathogenesis of foot-and-mouth disease in cattle after aerosol inoculation. Identification of the nasopharynx as the primary site of infection. Vet Pathol 47:1048–1063.  https://doi.org/10.1177/0300985810372509CrossRefPubMedGoogle Scholar
  12. Arzt J, Pacheco JM, Smoliga GR et al (2014) Foot-and-mouth disease virus virulence in cattle is co-determined by viral replication dynamics and route of infection. Virology 452:12–22.  https://doi.org/10.1016/j.virol.2014.01.001CrossRefPubMedGoogle Scholar
  13. Bachrach HL (1968) Foot-And-Mouth Disease. Annu Rev Microbiol 22:201–244.  https://doi.org/10.1146/annurev.mi.22.100168.001221CrossRefPubMedGoogle Scholar
  14. Baxt B, Becker Y (1990) The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 4:73–83CrossRefPubMedGoogle Scholar
  15. Belsham G (1993) Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog Biophys Mol Biol 60:241–260CrossRefPubMedGoogle Scholar
  16. Belsham GJ (2005) Translation and replication of FMDV RNA. Curr Top Microbiol Immunol 288:43–70PubMedGoogle Scholar
  17. Blanco E, Guerra B, De La Torre BG et al (2016) Full protection of swine against foot-and-mouth disease by a bivalent B-cell epitope dendrimer peptide. Antiviral Res 129:74–80.  https://doi.org/10.1016/j.antiviral.2016.03.005CrossRefPubMedGoogle Scholar
  18. Borrego B, Argilaguet JM, Pérez-Martín E et al (2011) A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge. Antiviral Res.  https://doi.org/10.1016/j.antiviral.2011.07.017CrossRefPubMedGoogle Scholar
  19. Borrego B, Camarero JA, Mateu MG, Domingo E (1995) A highly divergent antigenic site of foot-and-mouth disease virus retains its immunodominance. Viral Immunol 8:11–8.  https://doi.org/10.1089/vim.1995.8.11CrossRefPubMedGoogle Scholar
  20. Brito BP, Rodriguez LL, Hammond JM, et al (2015) Review of the Global Distribution of Foot-and-Mouth Disease Virus from 2007 to 2014. Transbound Emerg Dis 1–17. doi: 10.1111/tbed.12373CrossRefPubMedGoogle Scholar
  21. Brown F (2003) The history of research in foot-and-mouth disease. Virus Res 91:3–7CrossRefPubMedGoogle Scholar
  22. Burrows R (1966) Studies on the carrier state of cattle exposed to Foot-and-mouth disease virus. J Hyg (Lond) 64:81–90.  https://doi.org/10.1017/S0022172400040365CrossRefGoogle Scholar
  23. Burrows R, Mann JA, Garland AJM et al (1981) The pathogenesis of natural and simulated natural Foot-and-Mouth disease infection in cattle. J Comp Pathol 91:599–609CrossRefPubMedGoogle Scholar
  24. Cao Y (2014) Adjuvants for foot-and-mouth disease virus vaccines: recent progress. Expert Rev Vaccines 13:1377–1385.  https://doi.org/10.1586/14760584.2014.963562CrossRefPubMedGoogle Scholar
  25. Cao Y, Li D, Fu Y et al (2017) Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs. Antiviral Res 140:133–141.  https://doi.org/10.1016/j.antiviral.2017.01.023CrossRefPubMedGoogle Scholar
  26. Cao Y, Lu Z, Li D et al (2014) Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C). Vet Microbiol 168:294–301.  https://doi.org/10.1016/j.vetmic.2013.11.023CrossRefPubMedGoogle Scholar
  27. Cao Y, Lu Z, Li Y et al (2013) Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs. Antiviral Res 97:145–153.  https://doi.org/10.1016/j.antiviral.2012.11.009CrossRefPubMedGoogle Scholar
  28. Cao Y, Lu Z, Liu Z (2016) Foot-and-mouth disease vaccines: progress and problems. Expert Rev Vaccines 584(14760584):1140042.  https://doi.org/10.1586/14760584.2016.1140042CrossRefGoogle Scholar
  29. Caron L, Brum MCS, Moraes MP et al (2005) Granulocyte-macrophage colony-stimulating factor does not increase the potency or efficacy of a foot-and-mouth disease virus subunit vaccine. Pesqui Vet Bras 25:150–158CrossRefGoogle Scholar
  30. Carrillo C, Wigdorovitz A, Oliveros JC, et al (1998) Protective Immune Response to Foot-and-Mouth Disease Virus with VP1 Expressed in Transgenic Plants. 72:1688–1690.Google Scholar
  31. Carrillo C, Wigdorovitz A, Trono K et al (2001) Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants. Viral Immunol 14:49–57CrossRefPubMedGoogle Scholar
  32. Cedillo-Barrón L, Foster-Cuevas M, Belsham GJ et al (2001) Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J Gen Virol 82:1713–1724CrossRefPubMedGoogle Scholar
  33. Chinsangaram J, Mason PW, Grubman MJ (1998) Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 16:1516–1522.  https://doi.org/10.1016/S0264-410X(98)00029-2CrossRefPubMedGoogle Scholar
  34. Cubillos C, de la Torre BG, Jakab A et al (2008) Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. J Virol 82:7223–30.  https://doi.org/10.1128/JVI.00401-08CrossRefPubMedPubMedCentralGoogle Scholar
  35. Dawe PS, Flanagan FO, Madekurozwa RL et al (1994a) Natural transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle in a wildlife area of Zimbabwe. Vet Rec 134:230–232CrossRefPubMedGoogle Scholar
  36. Dawe PS, Sorensen K, Ferris NP et al (1994b) Experimental transmission of foot-and-mouth disease virus from carrier African buffalo (Syncerus caffer) to cattle in Zimbabwe. Vet Rec 134:211–5CrossRefPubMedGoogle Scholar
  37. Di Nardo A, Libeau G, Chardonnet B et al (2015) Serological profile of foot-and-mouth disease in wildlife populations of West and Central Africa with special reference to Syncerus caffer subspecies. Vet Res 46:77.  https://doi.org/10.1186/s13567-015-0213-0CrossRefPubMedPubMedCentralGoogle Scholar
  38. Diaz-San Segundo F, Medina GN, Stenfeldt C et al (2016) Foot-and-mouth disease vaccines. Vet Microbiol.  https://doi.org/10.1016/j.vetmic.2016.12.018CrossRefPubMedGoogle Scholar
  39. Dicara D, Burman A, Clark S et al (2008) Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin alphavbeta6: implications for infectiousness. J Virol 82:1537–46.  https://doi.org/10.1128/JVI.01480-07CrossRefPubMedGoogle Scholar
  40. DiMarchi R, Brooke G, Gale C, et al (1986) Protection of cattle against foot-and-mouth disease by a synthetic peptide.CrossRefPubMedGoogle Scholar
  41. Doel TR (2003) FMD vaccines. Virus Res 91:81–99CrossRefPubMedGoogle Scholar
  42. Doel TR, Williams L, Barnett PV (1994) Emergency vaccination against foot-and-mouth disease: Rate of development of immunity and its implications for the carrier state. Vaccine 12:592–600.  https://doi.org/10.1016/0264-410X(94)90262-3CrossRefPubMedGoogle Scholar
  43. Domingo E, Baranowski E, Escarmı́s C, Sobrino F (2002) Foot-and-mouth disease virus. Comp Immunol Microbiol Infect Dis 25:297–308. doi: 10.1016/S0147-9571(02)00027-9CrossRefPubMedGoogle Scholar
  44. Donaldson AI (1987) Foot-and-mouth disease: the principal features. Irish Vet J 41:325–327Google Scholar
  45. Donaldson AI (1997) Risks of spreading foot and mouth disease through milk and dairy products. Rev Sci Tech 16:117–24CrossRefPubMedGoogle Scholar
  46. Donaldson AI, Alexandersen S (2001) Relative resistance of pigs to infection by natural aerosols of FMD virus. Vet Rec 148:600–2CrossRefPubMedGoogle Scholar
  47. Donaldson AI, Herniman KAJ, Parker J, Sellers RF (1970) Further investigations on the airborne excretion of foot and mouth disease virus. J Hyg, Camb 68:557–564.  https://doi.org/10.1016/B978-0-12-382219-2.00490-7CrossRefGoogle Scholar
  48. Dus Santos MJ, Carrillo C, Ardila F et al (2005) Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen. Vaccine 23:1838–43.  https://doi.org/10.1016/j.vaccine.2004.11.014CrossRefPubMedGoogle Scholar
  49. Dus Santos MJ, Wigdorovitz A, Trono K et al (2002) A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine 20:1141–1147CrossRefPubMedGoogle Scholar
  50. Fowler VL, Bashiruddin JB, Maree FF et al (2011) Foot-and-mouth disease marker vaccine: Cattle protection with a partial VP1 G-H loop deleted virus antigen. Vaccine 29:8405–8411.  https://doi.org/10.1016/j.vaccine.2011.08.035CrossRefPubMedGoogle Scholar
  51. Fox G, Parry NR, Barnett PV et al (1989) The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol 70(Pt 3):625–37.  https://doi.org/10.1099/0022-1317-70-3-625CrossRefPubMedGoogle Scholar
  52. Fukai K, Yamada M, Morioka K et al (2015) Dose-dependent responses of pigs infected with foot-and-mouth disease virus O/JPN/2010 by the intranasal and intraoral routes. Arch Virol 160:129–139.  https://doi.org/10.1007/s00705-014-2239-4CrossRefPubMedGoogle Scholar
  53. Gailiunas P, Cottral GE (1966) Presence and persistence of foot-and-mouth disease virus in bovine skin. J Bacteriol 91:2333–2338PubMedPubMedCentralGoogle Scholar
  54. Ganges L, Borrego B, Fernández-Pacheco P, et al (2011) DNA immunization of pigs with foot-and-mouth disease virus minigenes: From partial protection to disease exacerbation.Google Scholar
  55. Gay CG, Salt J, Balaski C (2003) Challenges and opportunities in developing and marketing vaccines for OIE List A and emerging animal diseases. Dev Biol (Basel) 114:243–50Google Scholar
  56. Gloster J, Sellers RF, Donaldson AI (1982) Long distance transport of foot-and-mouth disease virus over the sea. Vet Rec 110:47–52CrossRefPubMedGoogle Scholar
  57. Goodwin S, Tuthill TJ, Arias A et al (2009) Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner. J Virol 83:11275–11282.  https://doi.org/10.1128/JVI.01263-09CrossRefPubMedPubMedCentralGoogle Scholar
  58. Grubman M, Moraes M, Schutta C et al (2010) Adenovirus serotype 5-vectored foot-and-mouth disease subunit vaccines: the first decade. Future Virol 5:51–64CrossRefGoogle Scholar
  59. Grubman MJ, Baxt B (2004) Foot-and-Mouth Disease. 17:465–493.  https://doi.org/10.1128/CMR.17.2.465CrossRefGoogle Scholar
  60. Grubman MJ, Lewis S a, Morgan DO (1993) Protection of swine against foot-and-mouth disease with viral capsid proteins expressed in heterologous systems. Vaccine 11:825–9CrossRefPubMedGoogle Scholar
  61. Grubman MJ, Segundo FD, Perez-martin E, Service I (2012) Use of replication-defective adenoviruses to develop vaccines and biotherapeutics against foot-and-mouth disease. Future Virol 7:767–778CrossRefGoogle Scholar
  62. Gullberg M, Muszynski B, Organtini LJ et al (2013) Assembly and characterization of foot-and-mouth disease virus empty capsid particles expressed within mammalian cells. J Gen Virol 94:1769–1779.  https://doi.org/10.1099/vir.0.054122-0CrossRefPubMedGoogle Scholar
  63. Guo H-C, Sun S-Q, Jin Y et al (2013) Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet Res 44:48.  https://doi.org/10.1186/1297-9716-44-48CrossRefPubMedPubMedCentralGoogle Scholar
  64. Habiela M, Seago J, Perez-Martin E et al (2014) Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine induced immunity. J Gen Virol 95:2329–2345.  https://doi.org/10.1099/vir.0.068270-0CrossRefPubMedPubMedCentralGoogle Scholar
  65. Henderson WM (1948) A consideration of some of the factors concerned in intracutaneous injection of cattle. J Pathol Bacteriol 60:137–139CrossRefPubMedGoogle Scholar
  66. Hughes GJ, Mioulet V, Kitching RP et al (2002) Foot-and-mouth disease virus infection of sheep: implications for diagnosis and control. Vet Rec 150:724–7CrossRefPubMedGoogle Scholar
  67. Jackson T, Clark S, Berryman S et al (2004) Integrin alphavbeta 8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. J Virol 78:4533–40CrossRefPubMedPubMedCentralGoogle Scholar
  68. Jackson T, Mould AP, Sheppard D, King AMQ (2002) Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus. J Virol 76:935–41CrossRefPubMedPubMedCentralGoogle Scholar
  69. Jackson T, Sheppard D, Denyer M et al (2000) The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus. J Virol 74:4949–56CrossRefPubMedPubMedCentralGoogle Scholar
  70. Jiang L, Li Q, Li M et al (2006) A modified TMV-based vector facilitates the expression of longer foreign epitopes in tobacco. Vaccine 24:109–115.  https://doi.org/10.1016/j.vaccine.2005.09.060CrossRefPubMedGoogle Scholar
  71. Juleff N, Windsor M, Reid E et al (2008) Foot-and-mouth disease virus persists in the light zone of germinal centres. PLoS One 3:e3434.  https://doi.org/10.1371/journal.pone.0003434CrossRefPubMedPubMedCentralGoogle Scholar
  72. Kitching RP (2002) Clinical variation in foot and mouth disease: cattle. Rev Sci Tech 21:499–504.  https://doi.org/10.20506/rst.21.3.1367CrossRefPubMedGoogle Scholar
  73. Kitching RP, Alexandersen S (2002) Clinical variation in foot and mouth disease: pigs. Rev Sci Tech 21:513–8CrossRefPubMedGoogle Scholar
  74. Kitching RP, Hughes GJ (2002) Clinical variation in foot and mouth disease: sheep and goats. Rev Sci Tech 21:505–512CrossRefPubMedGoogle Scholar
  75. Kleina LG, Grubman MJ (1992) Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus. J Virol 66:7168–75PubMedPubMedCentralGoogle Scholar
  76. Knight-Jones TJD, Rushton J (2013) The economic impacts of foot and mouth disease - What are they, how big are they and where do they occur? Prev Vet Med 112:162–173.  https://doi.org/10.1016/j.prevetmed.2013.07.013CrossRefGoogle Scholar
  77. Knowles NJ, Samuel AR, Davies PR et al (2001) Outbreak of foot-and-mouth disease virus serotype O in the UK caused by a pandemic strain. Vet Rec 148:258–9PubMedGoogle Scholar
  78. Knowles NJ, Samuel AR, Davies PR et al (2005) Pandemic strain of foot-and-mouth disease virus serotype O. Emerg Infect Dis 11:1887–1893.  https://doi.org/10.3201/eid1112.050908CrossRefPubMedPubMedCentralGoogle Scholar
  79. Kushnir N, Streatfield SJ, Yusibov V (2012) Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development. Vaccine 31:58–83.  https://doi.org/10.1016/j.vaccine.2012.10.083CrossRefPubMedPubMedCentralGoogle Scholar
  80. Lee C-D, Sun H-C, Hu S-M et al (2008) An improved SUMO fusion protein system for effective production of native proteins. Protein Sci 17:1241–8.  https://doi.org/10.1110/ps.035188.108CrossRefPubMedPubMedCentralGoogle Scholar
  81. Lentz EM, Segretin ME, Morgenfeld MM et al (2010) High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants. Planta 231:387–395.  https://doi.org/10.1007/s00425-009-1058-4CrossRefPubMedGoogle Scholar
  82. Li C, Yamagishi N, Kaido M, Yoshikawa N (2014a) Presentation of epitope sequences from foreign viruses on the surface of apple latent spherical virus particles. Virus Res 190:118–126.  https://doi.org/10.1016/j.virusres.2014.07.013CrossRefPubMedGoogle Scholar
  83. Li P, Lu Z, Bai X et al (2014b) Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine. Vet Res 45:1–11.  https://doi.org/10.1186/1297-9716-45-51CrossRefGoogle Scholar
  84. Li Y, Aggarwal N, Takamatsu H et al (2006a) Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O. Vaccine 24:4602–4606CrossRefPubMedGoogle Scholar
  85. Li Y, Stirling CMA, Denyer MS et al (2008a) Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost. Vaccine 26:2647–2656.  https://doi.org/10.1016/j.vaccine.2008.01.037CrossRefPubMedGoogle Scholar
  86. Li Y, Sun M, Liu J et al (2006b) High expression of foot-and-mouth disease virus structural protein VP1 in tobacco chloroplasts. Plant Cell Rep 25:329–333.  https://doi.org/10.1007/s00299-005-0074-5CrossRefPubMedGoogle Scholar
  87. Li Z, Yi Y, Yin X et al (2008b) Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine. PLoS One 3:1–7.  https://doi.org/10.1371/journal.pone.0002273CrossRefGoogle Scholar
  88. Li Z, Yi Y, Yin X et al (2012) Development of a Foot-and-Mouth Disease Virus Serotype A Empty Capsid Subunit Vaccine Using Silkworm (Bombyx mori) Pupae. PLoS One 7:e43849.  https://doi.org/10.1371/journal.pone.0043849CrossRefPubMedPubMedCentralGoogle Scholar
  89. Loeffler F, Frosch P (1897) Summarischer bericht ueber der ergebnisse der untersuchungen zur erforschung der maul- und klauenseuche. Zentbl Bakteriol Parasitenkd Infekt Hyg 22:257–259Google Scholar
  90. Macdonald J, Doshi K, Dussault M et al (2015) Bringing plant-based veterinary vaccines to market: Managing regulatory and commercial hurdles ☆. Biotechnol Adv 33:1572–1581.  https://doi.org/10.1016/j.biotechadv.2015.07.007CrossRefPubMedGoogle Scholar
  91. Mason PW, Grubman MJ, Baxt B (2003) Molecular basis of pathogenesis of FMDV. Virus Res 91:9–32.  https://doi.org/10.1016/S0168-1702(02)00257-5CrossRefPubMedGoogle Scholar
  92. Mason PW, Piccone ME, McKenna TSC et al (1997) Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 227:96–102.  https://doi.org/10.1006/viro.1996.8309CrossRefPubMedGoogle Scholar
  93. Mateu MG, Camarero JA, Giralt E et al (1995) Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206:298–306.  https://doi.org/10.1016/S0042-6822(95)80045-XCrossRefPubMedGoogle Scholar
  94. Mayr GA, Chinsangaram J, Grubman MJ (1999) Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 263:496–506CrossRefPubMedGoogle Scholar
  95. Mayr GA, O’Donnell V, Chinsangaram J et al (2001) Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine 19:2152–62CrossRefPubMedGoogle Scholar
  96. McKenna TS, Lubroth J, Rieder E et al (1995) Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J Virol 69:5787–90PubMedPubMedCentralGoogle Scholar
  97. Mignaqui AC, Ruiz V, Perret S et al (2013) Transient Gene Expression in Serum-Free Suspension-Growing Mammalian Cells for the Production of Foot-and-Mouth Disease Virus Empty Capsids. PLoS One 8:e72800.  https://doi.org/10.1371/journal.pone.0072800CrossRefPubMedPubMedCentralGoogle Scholar
  98. Mingxiao M, Ningyi J, Jaun L et al (2007) Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18. Antiviral Res 76:59–67.  https://doi.org/10.1016/j.antiviral.2007.05.003CrossRefPubMedGoogle Scholar
  99. Monaghan P (2005) The alfa(v)beta6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J Gen Virol 86:2769–2780.  https://doi.org/10.1099/vir.0.81172-0CrossRefPubMedGoogle Scholar
  100. Montague NP, Thuenemann EC, Saxena P et al (2011) Recent advances of Cowpea mosaic virus-based particle technology. Hum Vaccin 7:383–390.  https://doi.org/10.4161/hv.7.3.14989CrossRefPubMedGoogle Scholar
  101. Moonen P, Schrijver R (2000) Carriers of foot-and-mouth disease virus: A review. Vet Q 22:193–197.  https://doi.org/10.1080/01652176.2000.9695056CrossRefPubMedGoogle Scholar
  102. Moraes M, Mayr G, Mason P, Grubman M (2002) Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20:1631–1639.  https://doi.org/10.1016/S0264-410X(01)00483-2CrossRefPubMedGoogle Scholar
  103. Moraes MP, Chinsangaram J, Brum MC, Grubman MJ (2003) Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22:268–279.  https://doi.org/10.1016/S0264-410X(03)00560-7CrossRefPubMedGoogle Scholar
  104. Moraes MP, Segundo FD-S, Dias CC et al (2011) Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response. Vaccine 29:9431–40.  https://doi.org/10.1016/j.vaccine.2011.10.037CrossRefPubMedGoogle Scholar
  105. Murphy C, Bashiruddin JB, Quan M et al (2010) Foot-and-mouth disease viral loads in pigs in the early, acute stage of disease. Vet Rec 166:10–4.  https://doi.org/10.1136/vr.b5583CrossRefPubMedGoogle Scholar
  106. Muthamilselvan T, Lee CW, Cho YH et al (2016) A transgenic plant cell-suspension system for expression of epitopes on chimeric Bamboo mosaic virus particles. Plant Biotechnol J 14:231–239.  https://doi.org/10.1111/pbi.12377CrossRefPubMedGoogle Scholar
  107. Noad R, Roy P (2003) Virus-like particles as immunogens. Trends Microbiol 11:438–444.  https://doi.org/10.1016/S0966-842X(03)00208-7CrossRefPubMedGoogle Scholar
  108. Oem J-K, Park J-H, Lee K-N et al (2007) Characterization of recombinant foot-and-mouth disease virus pentamer-like structures expressed by baculovirus and their use as diagnostic antigens in a blocking ELISA. Vaccine 25:4112–4121CrossRefPubMedGoogle Scholar
  109. Pacheco J, Brum M, Moraes M et al (2005) Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 337:205–209CrossRefPubMedGoogle Scholar
  110. Pacheco JM, Arzt J, Rodriguez LL (2010) Early events in the pathogenesis of foot-and-mouth disease in cattle after controlled aerosol exposure. Vet J 183:46–53.  https://doi.org/10.1016/j.tvjl.2008.08.023CrossRefPubMedGoogle Scholar
  111. Pacheco JM, Lee K-N, Eschbaumer M et al (2016) Evaluation of Infectivity, Virulence and Transmission of FDMV Field Strains of Serotypes O and A Isolated In 2010 from Outbreaks in the Republic of Korea. PLoS One 11:e0146445.  https://doi.org/10.1371/journal.pone.0146445CrossRefPubMedPubMedCentralGoogle Scholar
  112. Pacheco JM, Tucker M, Hartwig E et al (2012) Direct contact transmission of three different foot-and-mouth disease virus strains in swine demonstrates important strain-specific differences. Vet J 193:456–463.  https://doi.org/10.1016/j.tvjl.2012.01.012CrossRefPubMedGoogle Scholar
  113. Pan L, Zhang Y, Wang Y et al (2008) Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1-2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs. Vet Immunol Immunopathol 121:83–90CrossRefPubMedGoogle Scholar
  114. Parida S (2009) Vaccination against foot-and-mouth disease virus: strategies and effectiveness. Expert Rev Vaccines 8:347–365.  https://doi.org/10.1586/14760584.8.3.347CrossRefPubMedGoogle Scholar
  115. Park J (2013) Requirements for improved vaccines against foot-and-mouth disease epidemics. Clin Exp Vaccine Res 2:8–18.  https://doi.org/10.7774/cevr.2013.2.1.8CrossRefPubMedPubMedCentralGoogle Scholar
  116. Pena L, Moraes MP, Koster M et al (2008) Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine. Vaccine 26:5689–5699.  https://doi.org/10.1016/j.vaccine.2008.08.022CrossRefPubMedGoogle Scholar
  117. Polacek C, Gullberg M, Li J, Belsham GJ (2013) Low levels of foot-and-mouth disease virus 3C protease expression are required to achieve optimal capsid protein expression and processing in mammalian cells. J Gen Virol 94:1249–1258.  https://doi.org/10.1099/vir.0.050492-0CrossRefPubMedGoogle Scholar
  118. Porta C, Kotecha A, Burman A et al (2013a) Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe. Protective Vaccine Antigen. PLoS Pathog 9:e1003255.  https://doi.org/10.1371/journal.ppat.1003255CrossRefPubMedGoogle Scholar
  119. Porta C, Spall VE, Findlay KC et al (2003) Cowpea mosaic virus-based chimaeras: Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses. Virology 310:50–63.  https://doi.org/10.1016/S0042-6822(03)00140-5CrossRefPubMedGoogle Scholar
  120. Porta C, Spall VE, Loveland J et al (1994) Development of Cowpea Mosaic Virus as a High-Yielding System for the Presentation of Foreign Peptides. Virology 202:949–955.  https://doi.org/10.1006/viro.1994.1417CrossRefPubMedGoogle Scholar
  121. Porta C, Xu X, Loureiro S et al (2013b) Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity. J Virol Methods 187:406–412.  https://doi.org/10.1016/j.jviromet.2012.11.011CrossRefPubMedPubMedCentralGoogle Scholar
  122. Quan M, Murphy CM, Zhang Z et al (2009) Influence of Exposure Intensity on the Efficiency and Speed of Transmission of Foot-and-Mouth Disease. J Comp Pathol 140:225–237.  https://doi.org/10.1016/j.jcpa.2008.12.002CrossRefPubMedGoogle Scholar
  123. Quan M, Murphy CM, Zhang Z, Alexandersen S (2004) Determinants of Early Foot-and-Mouth Disease Virus Dynamics in Pigs. J Comp Pathol 131:294–307.  https://doi.org/10.1016/j.jcpa.2004.05.002CrossRefPubMedGoogle Scholar
  124. Racaniello V (2001) Picornaviridae: the viruses and their replication. Fields Virology, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 685–722Google Scholar
  125. Rao JP, Agrawal P, Mohammad R et al (2012) Expression of VP1 protein of serotype A and O of foot-and-mouth disease virus in transgenic sunnhemp plants and its immunogenicity for guinea pigs. Acta Virol 56:91–99.  https://doi.org/10.4149/av_2012_02_91CrossRefPubMedGoogle Scholar
  126. Ren J, Yang L, Xu H et al (2011) CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle. Vaccine 29:7960–7965.  https://doi.org/10.1016/j.vaccine.2011.08.072CrossRefPubMedGoogle Scholar
  127. Robinson L, Knight-Jones TJD, Charleston B et al (2016) Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines. Transbound Emerg Dis 63:30–41.  https://doi.org/10.1111/tbed.12521CrossRefPubMedGoogle Scholar
  128. Rodriguez LL, Barrera J, Kramer E et al (2003) A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21:3751–3756.  https://doi.org/10.1016/S0264-410X(03)00364-5CrossRefPubMedGoogle Scholar
  129. Rodriguez LL, Gay CG (2011) Development of vaccines toward the global control and eradication of foot-and-mouth disease. Expert Rev Vaccines 10:377–87.  https://doi.org/10.1586/erv.11.4CrossRefPubMedGoogle Scholar
  130. Rohll JB, Moon DH, Evans DJ, Almond JW (1995) The 3’ untranslated region of picornavirus RNA: features required for efficient genome replication. J Virol 69:7835–44PubMedPubMedCentralGoogle Scholar
  131. Roosien J, Belsham GJ, Ryan MD et al (1990) Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J Gen Virol 71:1703–1711CrossRefPubMedGoogle Scholar
  132. Rueckert RR, Wimmer E (1984) Systematic nomenclature of picornavirus proteins. J Virol 50:957–9PubMedPubMedCentralGoogle Scholar
  133. Ruiz-Sáenz J, Goez Y, Tabares W, López-Herrera A (2009) Cellular Receptors for Foot and Mouth Disease Virus. Intervirology 52:201–212.  https://doi.org/10.1159/000226121CrossRefPubMedGoogle Scholar
  134. Ruiz V, Mozgovoj MV, Dus Santos MJ, Wigdorovitz A (2015) Plant-produced viral bovine vaccines: What happened during the last 10 years? Plant Biotechnol J 13:1071–1077.  https://doi.org/10.1111/pbi.12440CrossRefPubMedPubMedCentralGoogle Scholar
  135. Rweyemamu M, Roeder P, MacKay D et al (2008) Epidemiological patterns of foot-and-mouth disease worldwide. Transbound Emerg Dis 55:57–72.  https://doi.org/10.1111/j.1865-1682.2007.01013.xCrossRefPubMedGoogle Scholar
  136. Sa-Carvalho D, Rieder E, Baxt B et al (1997) Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 71:5115–23PubMedPubMedCentralGoogle Scholar
  137. Sangula AK, Siegismund HR, BelshamGJ, et al (2011) Low diversity of foot-and-mouth disease serotype C virus in Kenya: evidence for probable vaccine strain re-introductions in the field. Epidemiol Infect 139:189–196. doi: 10.1017/S0950268810000580CrossRefPubMedGoogle Scholar
  138. Santos TDL, Botton SDA, Weiblen R, Grubman MJ (2006) The Leader Proteinase of Foot-and-Mouth Disease Virus Inhibits the Induction of Beta Interferon mRNA and Blocks the Host Innate Immune Response. 80:1906–1914.  https://doi.org/10.1128/JVI.80.4.1906CrossRefGoogle Scholar
  139. Saunders K, Sainsbury F, Lomonossoff GP (2009) Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants. Virology 393:329–37.  https://doi.org/10.1016/j.virol.2009.08.023CrossRefPubMedGoogle Scholar
  140. Sellers R, Gloster J (2008) Foot-and-mouth disease: A review of intranasal infection of cattle, sheep and pigs. Vet J 177:159–168.  https://doi.org/10.1016/j.tvjl.2007.03.009CrossRefPubMedGoogle Scholar
  141. Sellers RF, Parker J (1969) Airborne excretion of foot-and-mouth disease virus.CrossRefPubMedGoogle Scholar
  142. Serrano P, Pulido MR, Sáiz M, Martínez-Salas E (2006) The 3’ end of the foot-and-mouth disease virus genome establishes two distinct long-range RNA-RNA interactions with the 5’ end region. J Gen Virol 87:3013–3022.  https://doi.org/10.1099/vir.0.82059-0CrossRefPubMedGoogle Scholar
  143. Shahan M (1962) Shahan : Virus of Foot-and-Mouth Disease. Ann N Y Acad Sci 101:444–454CrossRefPubMedGoogle Scholar
  144. Smith MT, Bennett AM, Grubman MJ, Bundy BC (2014) Foot-and-mouth disease: Technical and political challenges to eradication. VaccineCrossRefPubMedGoogle Scholar
  145. Sobrino F, Blanco E, García-Briones M, Ley V (1999) Synthetic peptide vaccines: foot-and-mouth disease virus as a model. Dev Biol Stand 101:39–43PubMedGoogle Scholar
  146. Sørensen JH, Mackay DK, Jensen CO, Donaldson AI (2000) An integrated model to predict the atmospheric spread of foot-and-mouth disease virus. Epidemiol Infect 124:577–90CrossRefPubMedPubMedCentralGoogle Scholar
  147. Stenfeldt C, Diaz-San Segundo F, de Los Santos T et al (2016a) The Pathogenesis of Foot-and-Mouth Disease in Pigs. Front Vet Sci 3:41.  https://doi.org/10.3389/fvets.2016.00041CrossRefPubMedPubMedCentralGoogle Scholar
  148. Stenfeldt C, Pacheco JM, Brito BP et al (2016b) Transmission of Foot-and-Mouth Disease Virus during the Incubation Period in Pigs. Front Vet Sci 3:105.  https://doi.org/10.3389/fvets.2016.00105CrossRefPubMedPubMedCentralGoogle Scholar
  149. Stenfeldt C, Pacheco JM, Rodriguez LL, Arzt J (2014a) Infection dynamics of foot-and-mouth disease virus in pigs using two novel simulated-natural inoculation methods. Res Vet Sci 96:396–405.  https://doi.org/10.1016/j.rvsc.2014.01.009CrossRefPubMedGoogle Scholar
  150. Stenfeldt C, Pacheco JM, Rodriguez LL, Arzt J (2014b) Early Events in the Pathogenesis of Foot-and-Mouth Disease in Pigs; Identification of Oropharyngeal Tonsils as Sites of Primary and Sustained Viral Replication. PLoS One 9:e106859.  https://doi.org/10.1371/journal.pone.0106859CrossRefPubMedPubMedCentralGoogle Scholar
  151. Stenfeldt C, Pacheco JM, Smoliga GR et al (2014c) Detection of Foot-and-mouth Disease Virus RNA and Capsid Protein in Lymphoid Tissues of Convalescent Pigs Does Not Indicate Existence of a Carrier State. Transbound Emerg Dis 63:152–164.  https://doi.org/10.1111/tbed.12235CrossRefPubMedGoogle Scholar
  152. Taboga O, Tami C, Carrillo E et al (1997) A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol 71:2606–14PubMedPubMedCentralGoogle Scholar
  153. Thomson G, Vosloo W, Bastos AD (2003) Foot and mouth disease in wildlife. Virus Res 91:145–161.  https://doi.org/10.1016/S0168-1702(02)00263-0CrossRefPubMedGoogle Scholar
  154. Thuenemann EC, Lenzi P, Love AJ, et al (2013) The Use of Transient Expression Systems for the Rapid Production of Virus-like Par- ticles in Plants.Google Scholar
  155. Toka FN, Golde WT (2013) Cell mediated innate responses of cattle and swine are diverse during foot-and-mouth disease virus (FMDV) infection: a unique landscape of innate immunity. Immunol Lett 152:135–43.  https://doi.org/10.1016/j.imlet.2013.05.007CrossRefPubMedGoogle Scholar
  156. Transparency Market Research (2015) In: Foot Mouth Dis. Vaccines Mark. http://www.transparencymarketresearch.com/foot-mouth-disease-vaccines.html. Accessed 1 Mar 2017
  157. Uddowla S, Hollister J, Pacheco JM et al (2012) A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. J Virol 86:11675–85.  https://doi.org/10.1128/JVI.01254-12CrossRefPubMedPubMedCentralGoogle Scholar
  158. Usha R, Rohll J, Spall V et al (1993) Expression of an animal virus antigenic site on the surface of a plant virus particle.pdf. Virology 197:366–374CrossRefPubMedGoogle Scholar
  159. Valarcher J-F, Leforban Y, Rweyemamu M et al (2008) Incursions of foot-and-mouth disease virus into Europe between 1985 and 2006. Transbound Emerg Dis 55:14–34.  https://doi.org/10.1111/j.1865-1682.2007.01010.xCrossRefPubMedGoogle Scholar
  160. Van Bekkum J, Frenkel H, Frederiks H, Frenkel S (1959) Observations on the carrier state of cattle exposed to foot- and-mouth disease virus. Tijdschriſt voor Diergeneeskd 84:1159–1164Google Scholar
  161. Verdaguer N, Mateu MG, Andreu D et al (1995) Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction. EMBO J 14:1690–6PubMedPubMedCentralCrossRefGoogle Scholar
  162. Vivek Srinivas VM, Basagoudanavar SH, Hosamani M (2016) IRES mediated expression of viral 3C protease for enhancing the yield of FMDV empty capsids using baculovirus system. Biologicals 4:1–5.  https://doi.org/10.1016/j.biologicals.2015.12.002CrossRefGoogle Scholar
  163. Wang CY, Chang TY, Walfield AM et al (2002) Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20:2603–2610.  https://doi.org/10.1016/S0264-410X(02)00148-2CrossRefPubMedGoogle Scholar
  164. Wang DM, Zhu JB, Peng M, Zhou P (2008) Induction of a protective antibody response to FMDV in mice following oral immunization with transgenic Stylosanthes spp. as a feedstuff additive. Transgenic Res 17:1163–1170.  https://doi.org/10.1007/s11248-008-9188-1CrossRefPubMedGoogle Scholar
  165. Wang G, Wang Y, Shang Y et al (2015) How foot-and-mouth disease virus receptor mediates foot-and-mouth disease virus infection. Virol J 12:9.  https://doi.org/10.1186/s12985-015-0246-zCrossRefPubMedPubMedCentralGoogle Scholar
  166. Wang Y, Shen Q, Jiang Y et al (2012) Immunogenicity of foot-and-mouth disease virus structural polyprotein P1 expressed in transgenic rice. J Virol Methods 181:12–17.  https://doi.org/10.1016/j.jviromet.2012.01.004CrossRefPubMedGoogle Scholar
  167. Wigdorovitz A, Carrillo C, Dus Santos M et al (1999a) Induction of a Protective Antibody Response to Foot and Mouth Disease Virus in Mice Following Oral or Parenteral Immunization with Alfalfa Transgenic Plants Expressing the Viral Structural Protein VP1 1. Virology 255:347–353CrossRefPubMedGoogle Scholar
  168. Wigdorovitz A, Pérez Filgueira DM, Robertson N et al (1999b) Protection of Mice against Challenge with Foot and Mouth Disease Virus (FMDV) by Immunization with Foliar Extracts from Plants Infected with Recombinant Tobacco Mosaic Virus Expressing the FMDV Structural Protein VP1. Virology 264:85–91.  https://doi.org/10.1006/viro.1999.9923CrossRefPubMedPubMedCentralGoogle Scholar
  169. Wu L, Jiang L, Zhou Z et al (2003a) Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector. Vaccine 21:4390–4398.  https://doi.org/10.1016/S0264-410X(03)00428-6CrossRefPubMedGoogle Scholar
  170. Wu Q, Moraes MP, Grubman MJ (2003b) Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine. Virus Res 93:211–219.  https://doi.org/10.1016/S0168-1702(03)00116-3CrossRefPubMedGoogle Scholar
  171. Xiao Y, Chen H-Y, Wang Y et al (2016) Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle. BMC Biotechnol 16:56.  https://doi.org/10.1186/s12896-016-0285-6CrossRefPubMedPubMedCentralGoogle Scholar
  172. Yang C-D, Liao J-T, Lai C-Y et al (2007) Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes. BMC Biotechnol 7:62.  https://doi.org/10.1186/1472-6750-7-62CrossRefPubMedPubMedCentralGoogle Scholar
  173. Zhang Y, Li J, Pu H et al (2010) Development of Tobacco necrosis virus A as a vector for efficient and stable expression of FMDV VP1 peptides. Plant Biotechnol J 8:506–523.  https://doi.org/10.1111/j.1467-7652.2010.00500.xCrossRefPubMedGoogle Scholar
  174. Zhang Z, Pan L, Ding Y et al (2015) Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle. Appl Microbiol Biotechnol 99:1389–98.  https://doi.org/10.1007/s00253-014-6129-1CrossRefPubMedGoogle Scholar
  175. Zhang ZD, Kitching RP (2001) The localization of persistent foot and mouth disease virus in the epithelial cells of the soft palate and pharynx. J Comp Pathol 124:89–94.  https://doi.org/10.1053/jcpa.2000.0431CrossRefPubMedGoogle Scholar
  176. Zlotnick A, Stray SJ (2003) How does your virus grow? Understanding and interfering with virus assembly. Trends Biotechnol 21:536–542.  https://doi.org/10.1016/j.tibtech.2003.09.012CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Instituto de Virología, Centro de Investigaciones en Ciencias Veterinarias y Agronómicas (CICVyA), Instituto Nacional de Tecnología Agropecuaria (INTA)Hurlingham, Buenos AiresArgentina
  2. 2.Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET)Buenos AiresArgentina

Personalised recommendations